OCUP

Ocuphire Pharma Inc.

This asset is no longer available for investment.

View all assets

Price

return (12m)

p/e

-2.43

p/bv

0.84

DIVIDEND YIELD

0.00%

OCUP price

Ocuphire Pharma

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment OCUP

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals OCUP

Valuation

P/E

-2.43

Sector -2.19

Industry 1.21

P/BV

0.84

Sector 2.22

Industry 2.11

P/Revenue (PSR)

2.09

Sector 2.01

Industry 0.78

EV/EBITDA

-4.12

Sector -17.81

Industry -25.30

EV/EBIT

-4.12

Sector -26.72

Industry -18.04

P/EBITDA

-2.38

Sector 0.36

Industry 0.18

P/EBIT

-2.37

Sector -3.34

Industry 1.26

P/Total Assets

0.77

Sector 1.23

Industry 0.86

P/Net Current Assets

0.84

Sector -27.35

Industry -12.37

P/Working Capital

0.84

Sector -4.54

Industry -49.48

EPS

-0.54

Sector -0.87

Industry -0.55

BVPS

1.56

Sector 3.80

Industry 5.36

Efficiency

Gross Margin

100.00%

Sector 43.36%

Industry 31.53%

EBITDA Margin

-750.45%

Sector -323.65%

Industry -73.39%

EBIT Margin

-750.45%

Sector -194.57%

Industry -11.94%

Operating Margin

-91.72%

Sector -24.37%

Industry -9.87%

Net Profit Margins

-85.73%

Sector -28.88%

Industry -19.76%

Asset Turnover

0.02

Sector 0.12

Industry 0.22

Profitability

ROE

-34.69%

Sector -33.82%

Industry -37.56%

ROA

-31.45%

Sector -29.63%

Industry -17.56%

ROIC

-45,016.22%

Sector -431.16%

Industry -111.59%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

10.68

Sector 1.84

Industry 1.14

Net Debt / EBITDA

0.00

Sector -1.47

Industry -31.86

Net Debt / EBIT

0.00

Sector -1.32

Industry 2.06

Net Debt / Equity

0.00

Sector -0.35

Industry 0.14

Gross Debt / Equity

0.00

Sector 0.14

Industry 0.51

Equity/Assets

0.91

Sector 0.42

Industry 0.25

Liabilities/Assets

0.91

Sector 0.46

Industry 0.46

Growth

5Y Revenue CAGR

674.79%

Sector -

Industry -

5Y Earnings CAGR

-24.29%

Sector -

Industry -

Fundamentals OCUP

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
OCUP Ocuphire Pharma Inc.	$0.00	-	0.00%	-2.43	0.84	-34.69%	-85.73%
LLY Eli Lilly and Compay	$1,280.34	83.05%	0.54%	39.62	31.24	78.84%	33.53%
ISRG Intuitive Surgical Inc.	$397.72	-17.36%	0.00%	45.09	7.73	17.15%	28.45%
SNY Sanofi	$45.83	-4.42%	4.04%	7.10	1.31	18.43%	13.81%
NVS Novartis AG	$160.31	31.78%	2.05%	22.57	6.87	30.41%	22.50%
TMO Thermo Fisher Scientific Inc.	$613.54	26.39%	0.30%	31.58	4.17	13.19%	15.04%
ABT Abbott Laboratories	$114.43	-11.62%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$94.13	4.71%	3.10%	24.50	2.35	9.59%	13.20%
GSK GlaxoSmithKline PLC	$52.88	41.51%	3.59%	15.15	4.28	28.24%	14.54%
CVS CVS Health Corporation	$93.65	37.68%	2.73%	25.48	1.56	6.12%	1.18%
BSX Boston Scientific Corp.	$52.01	-49.87%	0.00%	18.98	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$93.97	-25.21%	0.00%	20.36	5.96	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$562.20	-11.86%	0.00%	38.32	27.08	70.67%	25.03%
RMD ResMed Inc.	$230.65	-18.34%	1.07%	21.40	4.95	23.13%	26.94%
DHR Danaher Corporation	$211.50	0.79%	0.71%	35.81	2.73	7.61%	15.95%
HCA HCA Healthcare Inc.	$407.05	4.09%	0.74%	13.12	-27.97	-213.15%	8.77%
COHR Coherent Inc.	$287.47	217.68%	0.00%	79.32	5.68	7.16%	11.31%
PHG Koninklijke Philips NV	$27.62	4.58%	3.70%	20.19	1.98	9.80%	6.30%
SYK Stryker Corp.	$339.98	-9.77%	1.02%	34.97	5.44	15.55%	14.43%
INMD InMode Ltd.	$15.04	5.14%	0.00%	11.54	1.42	12.32%	20.69%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

OCUP Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Ocuphire Pharma

Ocuphire Pharma Inc.

Average Investor10 user rating

4.0 (1 people)

United States

8 years

Founded: 2018

2020

Time since IPO - 6 years

5

Employees

Ocuphire Pharma Inc. (United States) is listed on the Nasdaq and has a market capitalization of $34.32 million, with shareholders equity totaling $40.64 million.

The company employs approximately 5 people and operates in the Health sector, within the Main Medications industry.

Over the past 12 months, Ocuphire Pharma Inc. reported $16.45 million in revenue, generating net income of $-14.10 million.

Key financial metrics include a P/E ratio of -2.43, a price-to-book (P/B) ratio of 0.84, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker OCUP.

Market cap

$34.32 million

Net worth

$40.64 million

$40,640,000.00

Assets

$44.83 million

$44,830,000.00

Total Shares Outstanding

26.00 million

26,000,000

Average Daily Trading Volume

$127.58 Thousand

$127,577.88

Sector

Health

Industry

Main Medications

OCUP

OCUP revenue and profits

Financial Results OCUP

DRAG THE FRAME TO SEE MORE DATA

OCUP cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.65 36,41% (12M)

P/E

25.48

2.73%

ROE

6.12%

P/BV

1.56

CI - Cigna

$277.45 --6,37% (12M)

P/E

10.82

2.19%

ROE

16.04%

P/BV

1.74

CNC - Centene

$64.69 120,03% (12M)

P/E

-6.48

0.00%

ROE

-22.51%

P/BV

1.46

HUM - Humana

$378.02 32,24% (12M)

P/E

36.20

0.92%

ROE

6.63%

P/BV

2.40

SNY - Sanofi

$45.83 --5,73% (12M)

P/E

7.10

4.04%

ROE

18.43%

P/BV

1.31

LLY - Eli Lilly

$1,280.34 81,92% (12M)

P/E

39.62

0.54%

ROE

78.84%

P/BV

31.24

HCA - HCA Healthcare

$407.05 --0,11% (12M)

P/E

13.12

0.74%

ROE

-213.15%

P/BV

-27.97

NVS - Novartis

$160.31 28,43% (12M)

P/E

22.57

2.05%

ROE

30.41%

P/BV

6.87